To support demand for the company’s products and services, OMRON has taken actions to maintain some of its manufacturing operations to support life science industry customers with critical needs in lab automation and the production of test-kits and vaccines.

OMRON facilities have taken measures to ensure safety is a top priority. Where employees cannot work remotely, engineering controls, administrative controls and personal protective equipment measures have been implemented. These include installation of physical barriers, employee temperature checks, shift adjustments, physical distancing, good hygiene practices and regular work area sanitization. The company has also implemented enhanced paid leave policies.

“Employee safety is our top priority at all times,” says Jim Eberhart, president and chief operating officer of OMRON Management Center of America. “We are mindful of safety at our manufacturing facilities across the Americas during this time and we are taking extra steps to help keep our people and their families safe and healthy.”

In addition, OMRON employees across the country are also making individual contributions by joining in the effort to make personal protective gear (PPE) by hand-sewing hundreds of face masks and 3D-printing face shields for frontline healthcare workers at hospitals across the country.

To learn more about OMRON’s ongoing response to the COVID-19 pandemic in the Americas, please visit our website at automation.omron.com, or follow us on Facebook, Twitter, LinkedIn or Instagram.

About OMRON Foundation, Inc.
Founded in 1989, OMRON Foundation, Inc. (OFI) coordinates the charitable efforts of OMRON offices in the U.S. to achieve the greatest positive social impact. The Foundation is funded by OMRON's subsidiaries in the U.S., which contribute a portion of sales revenue to the Foundation. The Foundation divides its charitable resources among organizations benefiting education, people with disabilities, cultural programs, health, and other social concerns including disaster relief.